6th Year Perspective: Working with State Representative...
December 1, 2022 - Featured , Professional Advice / Opinions Featuring: Christina Swiger, PharmD Candidate c/o 2023By: Justin Budz, PharmD Candidate c/o 2023 Christina Swiger is a sixth-year pharmacy student at St. John’s University. Christina was inspired to pursue a career in healthcare by her mother who is a store manager at a community pharmacy. Growing up, Christina was able to aid in the care… |
|
AstraZeneca’s Farxiga is First Heart Failure Drug to ...
December 1, 2022 - Featured , In the News / Politics By: Jennifer Galvet, PharmD Candidate c/o 2024 Farxiga (dapagliflozin) is a first-in-class, oral, once daily sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated for improving glycemic control in type 2 diabetes (T2D), reducing the risk of cardiovascular (CV) death and hospitalization in heart failure (HF), and reducing the risk of sustained eGFR decline in chronic kidney… |
|
Evaluating the Risk of Neurodevelopmental Disorders fro...
December 1, 2022 - In the News / Politics By: Geraldine Ciaccio, PharmD Candidate c/o 2025 Pregnant women treated with antidepressants may no longer have to endure the worry that their medications will harm their newborn. Previous studies have shown a correlation between the use of antidepressants in pregnant patients and the prevalence of various birth defects, including cardiac defects, anencephaly, and gastroschisis,… |
|
FDA Approves Tzield (teplizumab-mzwv) to Delay Onset of...
December 1, 2022 - Featured , In the News / Politics By: Justin Budz, PharmD Candidate c/o 2023 Diabetes mellitus encompasses both chronic and reversible conditions that affect the body’s ability to utilize glucose. In 2019, about 28.7 million (8.7%) people in the United States (US) had diagnosed diabetes. Of this population, about 1.6 million (5.7%) people ages 20 or older and 244,000 (0.9%) people… |
|
Pediatric COVID-19 Immunization Schedules Updated with ...
December 1, 2022 - In the News / Politics By: Helen Li, PharmD Candidate c/o 2023 On June 18, 2022, Centers for Disease Control and Prevention (CDC) Director, Rochelle P. Walensky, M.D., M.P.H., endorsed the Advisory Committee on Immunization Practices’ recommendation to expand eligibility of Coronavirus Disease 2019 (COVID-19) vaccinations to children 6 months through 5 years of age.1 On August 31, 2022,… |
|
Rho Chi Talks: Valuable Networking Opportunities at Alu...
December 1, 2022 - Featured , Professional Advice / Opinions Featuring: Amanda Murray, PharmD Candidate c/o 2024 and Laura Cranston, B.S.PharmBy: Ashley Dao, PharmD Candidate c/o 2024 Alumni Insider’s View (AIV) is an annual program held in Washington D.C. that provides students from St. John’s University with the opportunity to explore nontraditional career pathways in pharmacy. Students are able to network with pharmacists that hold… |